Addiction Treatment Center of New England Inc
EIN: 04-2708645Brighton, MAZIP: 02135
501(c)(3)
Mission
To alleviate the physical, mental and spiritual anguish of drug addicion as experienced by the individual, the family, and community by using all available modalities including prevention.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $6.6M | $0 | $9.4M |
Compensation
Explore related organizations
Similar Organizations
AIDS SUPPORT GROUP OF CAPE COD INC
$7M revenueProvincetown, MA
Very similar revenue ($7M vs $6.6M)Same state (Massachusetts)Similar median compensation ($119k vs $139k)Similar size (9 vs 10 executives)
HOPE HOUSE INC
$6.7M revenueBoston, MA
Very similar revenue ($6.7M vs $6.6M)Same state (Massachusetts)Similar median compensation ($130k vs $139k)
St Mary's Center for Women &
$7M revenueDorchester, MA
Very similar revenue ($7M vs $6.6M)Same state (Massachusetts)Similar median compensation ($139k vs $139k)
EMPOWER SCHOOLS INC
$6M revenueBrighton, MA
Very similar revenue ($6M vs $6.6M)Same state (Massachusetts)Similar median compensation ($131k vs $139k)
FC GREATER BOSTON BOLTS INC
$6.1M revenueFramingham, MA
Very similar revenue ($6.1M vs $6.6M)Same state (Massachusetts)Comparable compensation levels
CENTERING HEALTHCARE INSTITUTE INC
$6.7M revenueBoston, MA
Very similar revenue ($6.7M vs $6.6M)Same state (Massachusetts)Comparable compensation levels
INSTITUTE FOR NONPROFIT PRACTICE INC
$6.7M revenueBoston, MA
Very similar revenue ($6.7M vs $6.6M)Same state (Massachusetts)Comparable compensation levels
THE CARROLL CENTER FOR THE BLIND INC
$7.9M revenueNewton, MA
Similar revenue ($7.9M vs $6.6M)Same state (Massachusetts)Similar median compensation ($136k vs $139k)
SHAKESPEARE & COMPANY INC
$6.2M revenueLenox, MA
Very similar revenue ($6.2M vs $6.6M)Same state (Massachusetts)
STEPPINGSTONE FOUNDATION INC
$7.4M revenueBoston, MA
Similar revenue ($7.4M vs $6.6M)Same state (Massachusetts)Similar median compensation ($147k vs $139k)
Learn more
Data from IRS Form 990 filings (2023).